197 related articles for article (PubMed ID: 11731187)
21. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
22. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
23. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
24. Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women.
Bouchard P; De Cicco-Nardone F; Spielmann D; Garcea N;
Gynecol Endocrinol; 2005 Sep; 21(3):142-8. PubMed ID: 16353319
[TBL] [Abstract][Full Text] [Related]
25. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
[TBL] [Abstract][Full Text] [Related]
26. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
[TBL] [Abstract][Full Text] [Related]
27. Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy.
Hirvonen E; Lamberg-Allardt C; Lankinen KS; Geurts P; Wilén-Rosenqvist G
Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():19-25. PubMed ID: 9389779
[TBL] [Abstract][Full Text] [Related]
28. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
29. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
Williams SR; Frenchek B; Speroff T; Speroff L
Am J Obstet Gynecol; 1990 Feb; 162(2):438-46. PubMed ID: 2309827
[TBL] [Abstract][Full Text] [Related]
30. Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators.
Symons J; Kempfert N; Speroff L
Obstet Gynecol; 2000 Sep; 96(3):366-72. PubMed ID: 10960627
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
32. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
[TBL] [Abstract][Full Text] [Related]
34. A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Koninckx PR; Spielmann D
Gynecol Endocrinol; 2005 Aug; 21(2):82-9. PubMed ID: 16294460
[TBL] [Abstract][Full Text] [Related]
35. Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.
Dören M; Schneider HP
Maturitas; 1996 Oct; 25(2):99-105. PubMed ID: 8905600
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group.
Cromie MA; Maile MH; Wajszczuk CP
Contraception; 2000 Jan; 61(1):51-9. PubMed ID: 10745070
[TBL] [Abstract][Full Text] [Related]
37. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
Rowan JP; Simon JA; Speroff L; Ellman H
Clin Ther; 2006 Jun; 28(6):921-32. PubMed ID: 16860174
[TBL] [Abstract][Full Text] [Related]
38. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations.
Mattsson LA; Bohnet HG; Gredmark T; Torhorst J; Hornig F; Hüls G
Obstet Gynecol; 1999 Jul; 94(1):61-5. PubMed ID: 10389719
[TBL] [Abstract][Full Text] [Related]
39. Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy.
Mattsson LÅ; Ipsen HE; Granqvist CJ; Kokot-Kierepa M;
Climacteric; 2015 Jun; 18(3):419-25. PubMed ID: 25603163
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of fully transdermal hormone replacement in sequential or continuous therapy at two doses of progestogen in postmenopausal women.
Ylikorkala O; Rozenberg S
Maturitas; 2000 Dec; 37(2):83-93. PubMed ID: 11137327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]